K08 AI077796/AI/NIAID NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2011	2
2012	3
2013	1
2014	1
2015	1
2024	0

1

Venezuelan equine encephalitis virus activity in the Gulf Coast region of Mexico, 2003-2010.

Adams AP, Navarro-Lopez R, Ramirez-Aguilar FJ, Lopez-Gonzalez I, Leal G, Flores-Mayorga JM, Travassos da Rosa AP, Saxton-Shaw KD, Singh AJ, Borland EM, Powers AM, Tesh RB, Weaver SC, Estrada-Franco JG. Adams AP, et al. PLoS Negl Trop Dis. 2012;6(11):e1875. doi: 10.1371/journal.pntd.0001875. Epub 2012 Nov 1. PLoS Negl Trop Dis. 2012. PMID: 23133685 Free PMC article.

2

Genetic and anatomic determinants of enzootic Venezuelan equine encephalitis virus infection of Culex (Melanoconion) taeniopus.

Kenney JL, Adams AP, Gorchakov R, Leal G, Weaver SC. Kenney JL, et al. PLoS Negl Trop Dis. 2012;6(4):e1606. doi: 10.1371/journal.pntd.0001606. Epub 2012 Apr 3. PLoS Negl Trop Dis. 2012. PMID: 22509419 Free PMC article.

3

Squalamine as a broad-spectrum systemic antiviral agent with therapeutic potential.

Zasloff M, Adams AP, Beckerman B, Campbell A, Han Z, Luijten E, Meza I, Julander J, Mishra A, Qu W, Taylor JM, Weaver SC, Wong GC. Zasloff M, et al. Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):15978-83. doi: 10.1073/pnas.1108558108. Epub 2011 Sep 19. Proc Natl Acad Sci U S A. 2011. PMID: 21930925 Free PMC article.

4

A chimeric Sindbis-based vaccine protects cynomolgus macaques against a lethal aerosol challenge of eastern equine encephalitis virus.

Roy CJ, Adams AP, Wang E, Leal G, Seymour RL, Sivasubramani SK, Mega W, Frolov I, Didier PJ, Weaver SC. Roy CJ, et al. Vaccine. 2013 Mar 1;31(11):1464-70. doi: 10.1016/j.vaccine.2013.01.014. Epub 2013 Jan 16. Vaccine. 2013. PMID: 23333212 Free PMC article.

5

Analysis of intrahost variation in Venezuelan equine encephalitis virus reveals repeated deletions in the 6-kilodalton protein gene.

Forrester NL, Guerbois M, Adams AP, Liang X, Weaver SC. Forrester NL, et al. J Virol. 2011 Sep;85(17):8709-17. doi: 10.1128/JVI.00165-11. Epub 2011 Jun 29. J Virol. 2011. PMID: 21715498 Free PMC article.

6

A Rodent Model of Chikungunya Virus Infection in RAG1 -/- Mice, with Features of Persistence, for Vaccine Safety Evaluation.

Seymour RL, Adams AP, Leal G, Alcorn MD, Weaver SC. Seymour RL, et al. PLoS Negl Trop Dis. 2015 Jun 26;9(6):e0003800. doi: 10.1371/journal.pntd.0003800. eCollection 2015. PLoS Negl Trop Dis. 2015. PMID: 26115459 Free PMC article.

7

Attenuation of Chikungunya virus vaccine strain 181/clone 25 is determined by two amino acid substitutions in the E2 envelope glycoprotein.

Gorchakov R, Wang E, Leal G, Forrester NL, Plante K, Rossi SL, Partidos CD, Adams AP, Seymour RL, Weger J, Borland EM, Sherman MB, Powers AM, Osorio JE, Weaver SC. Gorchakov R, et al. J Virol. 2012 Jun;86(11):6084-96. doi: 10.1128/JVI.06449-11. Epub 2012 Mar 28. J Virol. 2012. PMID: 22457519 Free PMC article.

8

Chikungunya vaccine candidate is highly attenuated and protects nonhuman primates against telemetrically monitored disease following a single dose.

Roy CJ, Adams AP, Wang E, Plante K, Gorchakov R, Seymour RL, Vinet-Oliphant H, Weaver SC. Roy CJ, et al. J Infect Dis. 2014 Jun 15;209(12):1891-9. doi: 10.1093/infdis/jiu014. Epub 2014 Jan 7. J Infect Dis. 2014. PMID: 24403555 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year